Evidence map›Paper›PMID 34297041›Full record

ArticleThe Biochemical journal2021

Histone mimics: more tales to read.

Yucong Yu, Hong Wen, Xiaobing Shi

Abstract read
In one paragraph

Article in The Biochemical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yucong YuDepartment of Epigenetics, Van Andel Institute, 333 Bostwick Ave. NE, Grand Rapids, Michigan 49503, U.S.A.
Hong WenDepartment of Epigenetics, Van Andel Institute, 333 Bostwick Ave. NE, Grand Rapids, Michigan 49503, U.S.A.
Xiaobing ShiDepartment of Epigenetics, Van Andel Institute, 333 Bostwick Ave. NE, Grand Rapids, Michigan 49503, U.S.A.ORCID 0000-0001-5242-8189

Funding

Role of GAS41 in Human CancerR01CA204020 · NCI · VAN ANDEL RESEARCH INSTITUTE · PI SHI, XIAOBING · 2016 to 2020
$2.0M
Discovery of small molecules targeting the histone acetylation reader ENLR01CA255506 · NCI · VAN ANDEL RESEARCH INSTITUTE · PI WEN, HONG · 2021 to 2024
$1.7M
NCI NIH HHS R01 CA204020NCI NIH HHS R01 CA255506
6 · The paper itself

Abstract

Post-translational modifications (PTMs) on histone proteins are known as epigenetic marks that demarcate the status of chromatin. These modifications are 'read' by specific reader proteins, which in turn recruit additional factors to modulate chromatin accessibility and the activity of the underlying DNA. Accumulating evidence suggests that these modifications are not restricted solely to histones, many non-histone proteins may function in a similar way through mimicking the histones. In this commentary, we briefly discuss a systematic study of the discovery of histone H3 N-terminal mimicry proteins (H3TMs), and their implications in chromatin regulation and drug discoveries.

Indexed as

Protein Processing, Post-TranslationalAnimalsChromatinChromatin Assembly and DisassemblyDNAHistonesHumansLysineMethylationModels, BiologicalChromatinDNAHistonesLysine

Identifiers

PMID34297041
PMCPMC9357511

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.